,brentuximab vedotin,trastuzumab deruxtecan
astrazeneca,daiichi sankyo,takeda,seagen
['echelon-1', 'enhertu', 'takeda', 'seagen']
 takeda / seagen os data in hl - echelon-1 is pretty impressive too. plenary tomorrow abstract 3: enhertu should be the highlight of #asco22
venture capital / waves / biotech / coffee / pharma